Resume
Peter Vanhoutte (DR1-CNRS)
Lab. Neurosciences Paris-Seine
CNRS/UMR-8246;
INSERM/UMR-S1130
Team leader:
Neuronal Signaling and Gene Regulations
Sorbonne Université, Paris
EDUCATION
-2009: Habilitation for
research supervision (HDR); Université Pierre & Marie Curie (UPMC).
-2000: PhD in Neuroscience; UPMC.
-1996: DEA in Neuroscience; UPMC
POSITIONS
2022-present: DR1-CNRS head of the SNRG team; Lab Neuroscience
Paris-Seine CNRS/UMR8246; INSERM/UMRS1130; Sorbonne University (SU; head: Dr H.Chneiweiss).
-2014-2022: DR2-CNRS co-head of the SNRG team with Dr J.Caboche; Lab
Neuroscience Paris-Seine CNRS/UMR8246; INSERM/UMRS1130; Sorbonne University
(SU; head: Dr H.Chneiweiss).
-2010-2013: CR1-CNRS co-head of the team “Signalisation
intracellulaire et Neuroadaptations” with Dr J.Caboche; CNRS/UMR7224;
INSERM/UMRS952; UPMC (head: Dr B.Giros)
-2003-2009: CR2/CR1-CNRS in the team « Signalisation Neuronale & Régulations Géniques » headed by Dr
J.Caboche ; UMR 7102 ; UPMC – Paris VI ; head : Dr
J.Mariani).
-2001-2003:
Post-doctoral fellow: Medical Research Council de Cambridge (UK) and department
of Neuroscience of Heidelberg University (head Dr H.Bading).
Teaching Activities/ PhD supervision
-2018-2022: Supervision of 4 PhD students. Two of them
defended their PhD, one of them is the recipient of a PhD prize from the
“Académie Nationale de Pharmacie”.
-2020-present: Co-head,
with Pr S.Betuing, of the M2 program “Neuroscience
of Psychiatric disorders” at SU and co-organizer/lecturer of the mandatory
training unit of this program.
-2015-2019: Lecturer on
“Molecular basis of memory” for M2 students at SU.
-Member of the
pedagogic team of the doctoral school “Cerveau,
Cognition, & Comportement”.
-Regular member of the scientific advisory board of
the doctoral school “Biosigne”;
Paris-Saclay.
Reviewing activities/Commissions of trust
-Editor at Molecular
& Cellular Neuroscience.
-Associate editor at
Frontiers in Molecular Neuroscience.
-Reviewer (?3/month) for Biol.Psychiatry,Sci.Rep., Neurobiol. Dis., Neuropharmacology Neurosciences, Mol. Cell. Neurosci., Mol. Basis
of Dis. etc…
-Regular grant reviewing for ANR; FRC, FRM, Fundacao para a Ciencia e a
tecnologia etc…
-2020-present: Member
of the executive board of the i-Bio
initiative; IDEX SU.
-Regular member of
evaluation panels for “Awards for research” at SU.
-Regular member of PhD/HDR juries as referee, examiner
or president (?4/year).
Valorization
Creation of the company MELKin-Pharma, which R&D activities are based on the valorization of 5 patents of
which I am co-inventor. I am co-founder, shareholder, and member of the
scientific board of MELKin-Pharma.
@font-face
{font-family:Dotum;
panose-1:2 11 6 0 0 1 1 1 1 1;
mso-font-alt:??;
mso-font-charset:129;
mso-generic-font-family:swiss;
mso-font-pitch:variable;
mso-font-signature:-1342176593 1775729915 48 0 524447 0;}@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;
mso-font-charset:0;
mso-generic-font-family:roman;
mso-font-pitch:variable;
mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;
mso-font-charset:0;
mso-generic-font-family:swiss;
mso-font-pitch:variable;
mso-font-signature:-536859905 -1073697537 9 0 511 0;}@font-face
{font-family:"\@Dotum";
panose-1:2 11 6 0 0 1 1 1 1 1;
mso-font-charset:129;
mso-generic-font-family:swiss;
mso-font-pitch:variable;
mso-font-signature:-1342176593 1775729915 48 0 524447 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal
{mso-style-unhide:no;
mso-style-qformat:yes;
mso-style-parent:"";
margin:0cm;
mso-pagination:widow-orphan;
font-size:12.0pt;
font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";}p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
{mso-style-priority:99;
mso-style-link:"Corps de texte Car";
margin-top:0cm;
margin-right:-23.55pt;
margin-bottom:6.0pt;
margin-left:0cm;
text-align:justify;
line-height:115%;
mso-pagination:widow-orphan;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-font-family:Calibri;
mso-bidi-font-family:"Times New Roman";
mso-fareast-language:EN-US;}a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
mso-themecolor:hyperlink;
text-decoration:underline;
text-underline:single;}a:visited, span.MsoHyperlinkFollowed
{mso-style-noshow:yes;
mso-style-priority:99;
color:#954F72;
mso-themecolor:followedhyperlink;
text-decoration:underline;
text-underline:single;}span.CorpsdetexteCar
{mso-style-name:"Corps de texte Car";
mso-style-priority:99;
mso-style-unhide:no;
mso-style-locked:yes;
mso-style-link:"Corps de texte";
mso-ansi-font-size:11.0pt;
mso-bidi-font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-ascii-font-family:Calibri;
mso-fareast-font-family:Calibri;
mso-hansi-font-family:Calibri;
mso-bidi-font-family:"Times New Roman";}.MsoChpDefault
{mso-style-type:export-only;
mso-default-props:yes;
font-family:"Calibri",sans-serif;
mso-ascii-font-family:Calibri;
mso-ascii-theme-font:minor-latin;
mso-fareast-font-family:Calibri;
mso-fareast-theme-font:minor-latin;
mso-hansi-font-family:Calibri;
mso-hansi-theme-font:minor-latin;
mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;
mso-font-kerning:0pt;
mso-ligatures:none;
mso-fareast-language:EN-US;}div.WordSection1
{page:WordSection1;}
